Boston, MA 10/09/2014 (wallstreetpr) – Cornerstone OnDemand, Inc. (NASDAQ:CSOD)’s share price began waning, soon after it announced the veracity in the deal of acquiring a privately held cloud data analytics company called Evolv Inc. The latter offered an exquisite data science and machine learning parlance.
Financial Matters
The proposed acquisition is expected to be charged $42.5 million in hard cash, and another $2 million in debt. Approximately 200,000 restricted stocks shall be further issued in the scheme of things. The Board of Directors of Evolv and Cornerstone OnDemand, Inc. (NASDAQ:CSOD) discussed at length, and okayed the acquisition. They conjectured that this transaction would hardly have any seasoned impact on the holistic financial metrics in FY 2014-15.
Evolv’s Expertise
Based in San Francisco, the organization –Evolve deals with recruitment , and evaluation of work experiences, job candidates and personalities for each of these profiles. The idea behind the acquisition is to own and expand the data analytics to help one’s employers take profound steps in taking decision making, besides augmenting the overall workforce performance .
Views On The Deal
Adam Miller, the company spokesperson from CSOD conferred that Evolv has a reputation to harp on, and would be the huge opportunity. The returns from Evolv shall be used to evolve into a profound leader, with immense scope to deliver.
The acquisition, that has been duly approved by the BoD concerned, has been given a notice period of 30 days to close and settle the payments. Further, a company spokesperson from Cornerstone OnDemand, Inc. (NASDAQ:CSOD) revealed that the company is looking forward to impactful results in 3Q14, as late as early October!
Falling Price
With the acquisition setting off, CSOD’s net share price fell off, trading down by 4.83%, thereby reaching the benchmark of $31.32, trading over 710,654 shares! CSOD is near its trough as its 1 year high report portrays a share price estimating at $61.85. The Cornerstone OnDemand, Inc. (NASDAQ:CSOD) stock seems to baffle analysts, as they seem divided whether to advise people to sell, buy or merely hold.
